Studies and research carried out over the last 16 years, in the field of electromagnetic interactions and human physiology, have led to the implementation of an innovative technology called M.I.T. (Molecular Imprinting Technology).

This technology allows, through electromagnetic signals produced by nanomaterials and/or oriented ionic charges, to induce molecular and metabolic biological effects on sensitive targets with a high specificity from a chemical and pharmacological point of view.

In detail, this technology allows, through the acquisition of the very weak electromagnetic activities of biologically active molecules such as molecules of active ingredients of drugs or endogenous molecules, for example, prostaglandins or cytokines, to induce on electric charges an orientation consistent with the electromagnetic activity of the molecule of interest and their stabilization, this allows, when they are excited or power a device, all the electromagnetic expression produced will be a vector of the biological and metabolic effects of the starting molecule without the need to use the chemical component .

The other equally important possibility is that of being able to induce signals on the target that oxidize and reduce the molecules in a selective way, determining the increase or decrease in the impedance of the chemical structure itself, consequently the expression or inhibition of the molecule.

It has been found over the years that the applications of M.I.T. they are multiple and embrace different sectors in the medical field, where it is possible to intervene by inducing anti-inflammatory, antioxidant, anti-edema effects and not only that but applications find outlets in the veterinary, zootechnics, botany and industrial fields.

Some M.I.T. products, thanks to the collaboration with university structures and public and private research institutes, have obtained certification as medical devices (DM) with CE marking and today these DM are present on the national and international market.